查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404775

日本次世代定序市場規模、佔有率、趨勢分析報告：按技術、按產品、按應用、按工作流程、按最終用途、細分市場預測，2024-2030 年

Japan Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product (Platforms, Consumables) By Application, By Workflow, By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

日本次世代定序市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年日本次世代定序市場規模將達到13.0567億美元，2024年至2030年複合年成長率為23.60%。

伴隨伴同性、個人化醫療的進步以及 NGS 技術臨床機會的增加等因素預計將推動市場成長。此外，由於消費者需求旺盛而導致市場競爭加劇以及專注於開發次世代定序產品和服務的市場參與者的崛起也是推動產業需求向前發展的重要因素。

成本下降正在加速次世代定序在臨床環境中的採用。此外，對基於臨床的 NGS 解決方案的需求不斷成長預計將在預測期內推動次世代定序產業的發展。基因組定序和 MPSS/NGS 的使用已成為罕見疾病診斷和分析、治療標靶識別和產前檢測的必要條件。 NGS 預計將在遺傳性疾病和感染疾病的治療中得到更多採用。此外，該公司還針對罕見疾病和遺傳疾病提供基於 NGS 的產品和服務。例如，2023年1月，日本NGS服務供應商Twist Bioscience Co., Ltd.宣布推出三款NGS標靶富集panel，支持遺傳性癌症研究和罕見疾病並輔助診斷。在該國營運的主要企業推出的此類產品預計將在預測期內推動市場成長。

伴同性診斷和個人化醫療的發展預計將推動次世代定序產品和服務的採用。多位腫瘤學家預測，NGS與伴同性診斷相結合將在個體化診斷和治療中發揮重要作用，NGS應用的需求將大幅增加。此外，監管機構也支持使用 NGS 進行伴同性診斷。例如，2021 年 9 月，日本厚生勞動省核准了Thermo Fisher Scientific 的伴同性診斷 (CDx) Oncomine Dx Target Test。 Oncomin 檢測已被核准為基於 NGS 的肺癌伴隨診斷。此類新興市場的開拓，加上監管支持，預計將在預測期內推動市場成長。

日本次世代定序市場報告亮點

  • 按產品分類，耗材細分市場在 2023 年佔據行業主導地位，銷售佔有率為 74.0%，這種主導地位可歸因於較低的測序成本和領先企業增加耗材的推出。
  • 按應用分類，腫瘤學是 2023 年該行業最大的收益貢獻者。相較之下，由於個人健康意識、親子鑑定和系譜創建的快速發展，消費者基因組學領域預計將成長最快。
  • 基於工作流程，定序細分市場將在 2023 年佔據主導地位。由於可用的定序平台多種多樣，該細分市場收益豐厚。
  • 從技術角度來看，標靶定序和重測序領域預計將在 2023 年佔據行業主導地位，並在預測期內實現最高成長率。
  • 根據最終用途，學術研究領域將在 2023 年佔據行業主導地位，因為許多學術機構都提供生物資訊學課程。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 日本次世代定序市場的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 日本次世代定序市場分析工具
    • SWOT 分析；按因素（政治、法律、經濟、技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章日本次世代定序市場：技術業務分析

  • 次世代定序市場：技術變化分析
  • 標靶定序和定序
  • 全基因組序列測定
  • 全EXOME定序

第5章日本次世代定序市場：產品業務分析

  • 次世代定序市場：產品變異分析
  • 平台
  • 消耗品
    • 樣品製備
    • 目標強化
    • 其他

第6章 日本次世代定序市場：應用業務分析

  • 次世代定序市場：應用變化分析
  • 腫瘤學
    • 診斷和篩檢
    • 研究性學習
  • 臨床調查
    • 感染疾病
    • 特發性疾病
    • 遺傳疾病
    • 非傳染性疾病/其他疾病
  • 生殖健康
    • NIPT
    • PGT
    • 新生兒基因篩檢
    • 單基因分析
  • HLA型檢測/免疫系統監測
  • 宏基因體學、流行病學、藥物研發
  • 農業基因組學與法醫學
  • 消費者基因體學

第7章 日本次世代定序市場：工作流程業務分析

  • 次世代定序市場：工作流程變異分析
  • 預測定序
  • 定序
  • 資料分析
    • 原始資料NG分析
    • 二次資料分析
    • 三級資料分析

第8章日本次世代定序市場：最終用途業務分析

  • 次世代定序市場：最終用途變異分析
  • 學術研究
  • 臨床調查
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他用戶

第9章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
  • 2023年主要企業市場佔有率分析
  • Participants Overview
    • Illumina, Inc
    • QIAGEN
    • Thermo Fisher Scientific, Inc
    • BGI
    • Pacific Biosciences
    • Bio Rad Laboratories
    • Oxford Nanopore Technologies, Inc
    • Myriad Genetics. Inc.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
Product Code: GVR-4-68040-156-5

Japan Next Generation Sequencing Market Growth & Trends:

The Japan next generation sequencing market size is expected to reach USD 1,305.67 million by 2030, registering a CAGR of 23.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the development of companion diagnostics and personalized medicine and rising clinical opportunities for NGS technology are projected to drive the market growth. In addition, rising competition in the market owing to high consumer demand and the rising emphasis of market players to develop next-generation sequencing products and services is another vital factor propelling industry demand forward.

With lowering costs, the adoption of next-generation sequencing in the clinical setting is boosting. Moreover, an increase in the demand for clinic-based NGS solutions is anticipated to propel the next generation sequencing industry over the forecast period. The utilization of genome sequencing and MPSS /NGS has become necessary for the diagnosis & analysis of rare diseases, and recognizing therapeutic targets, and for prenatal testing. NGS is anticipated to witness rising adoption in hereditary diseases and infectious disorder treatment. Furthermore, companies are providing products and services based on NGS for rare and hereditary diseases. For instance, in January 2023, Twist Bioscience Corporation, An NGS service provider in Japan, introduced three NGS target enrichment panels to support hereditary cancer research and rare diseases and support diagnostics. Such product launches by key players operating in the country are anticipated to drive market growth over the forecast period.

The developments of companion diagnostics and personalized medicines are anticipated to drive the adoption of next-generation sequencing products and services. Several oncologists expected that NGS combined with companion diagnostics could play a major role in personalized diagnostics and therapeutics, significantly increasing the demand for NGS applications. Furthermore, regulatory authorities are also supporting the use of NGS for companion diagnostics. For instance, in September 2021, the Ministry of Health, Labour, and Welfare (MHLW), Japan, authorized the Oncomine Dx Target Test, a companion diagnostic (CDx) from Thermo Fisher Scientific Inc. The Oncomine test was approved as an NGS-based CDx for lung cancer. Such developments, coupled with regulatory support, are anticipated to boost the market growth over the forecast period.

Japan Next Generation Sequencing Market Report Highlights:

  • Based on product, the consumables segment dominated the industry in 2023 with a revenue share of 74.0%, and this dominance can be attributed to the decrease in sequencing costs and increasing launches of consumables by major players
  • Based on application, the oncology segment was the largest revenue contributor for the industry in 2023. In contrast, the consumer genomics segment is expected to witness the fastest growth owing to the rapid development in personal health awareness, paternity testing, and genealogy
  • Based on workflow, the sequencing segment dominated the market in 2023. The higher revenue of the segment is attributed to the availability of various sequencing platforms
  • Based on technology, the targeted sequencing & resequencing segment dominated the industry in 2023 and is projected to register the highest growth rate during the forecast period
  • Based on end-use, the academic research segment dominated the industry in 2023 due to numerous academic institutes providing bioinformatics courses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. Workflow
    • 1.1.5. End-use
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Japan Next Generation Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Exponentially decreasing costs for genetic sequencing
      • 3.2.1.2. Development of companion diagnostics and personalized medicine
      • 3.2.1.3. Rise in competition among prominent market entities
      • 3.2.1.4. Rising clinical opportunity for NGS technology
      • 3.2.1.5. Technological advancements in cloud computing and data integration
      • 3.2.1.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer.
      • 3.2.1.7. Increasing prevalence of cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of computational efficiency for data management
      • 3.2.2.2. Non-value-based NGS reimbursement policy and regulation status
      • 3.2.2.3. Challenges associated with NGS implementation.
  • 3.3. Japan Next Generation Sequencing Market Analysis Tools
    • 3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Japan Next Generation Sequencing Market: Technology Business Analysis

  • 4.1. Next Generation Sequencing Market: Technology Movement Analysis
  • 4.2. Targeted Sequencing & Resequencing
    • 4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.1. DNA-based targeted sequencing & resequencing
      • 4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.2.1.2. RNA-based targeted sequencing & resequencing
      • 4.2.1.2.1. RNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3. Whole Genome Sequencing
    • 4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4. Whole Exome Sequencing
    • 4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Japan Next Generation Sequencing Market: Product Business Analysis

  • 5.1. Next Generation Sequencing Market: Product Movement Analysis
  • 5.2. Platforms
    • 5.2.1. Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1. Sequencing
      • 5.2.1.1.1. Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million
  • 5.3. Consumables
    • 5.3.1. Consumables market estimates and forecast, 2018 - 2030 (USD million)
    • 5.3.2. Sample Preparation
      • 5.3.2.1. Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Target Enrichment
      • 5.3.3.1. Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Japan Next Generation Sequencing Market: Application Business Analysis

  • 6.1. Next Generation Sequencing Market: Application Movement Analysis
  • 6.2. Oncology
    • 6.2.1. Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2. Diagnostics & Screening
      • 6.2.2.1. Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2. Oncology screening
      • 6.2.2.2.1. Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3. Companion diagnostics
      • 6.2.2.3.1. Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4. Other diagnostics
      • 6.2.2.4.1. Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.3. Research Studies
      • 6.2.3.1. Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3. Clinical investigation
    • 6.3.1. Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Idiopathic Diseases
      • 6.3.3.1. Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Inherited Diseases
      • 6.3.4.1. Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5. Non-Communicable/Other Diseases
      • 6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Reproductive Health
    • 6.4.1. Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2. NIPT
      • 6.4.2.1. NIPT market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2. Aneuploidy
      • 6.4.2.2.1. Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3. Microdeletions
      • 6.4.2.3.1. Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. PGT
      • 6.4.3.1. PGT market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. Newborn Genetic Screening
      • 6.4.4.1. Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Single Gene Analysis
      • 6.4.5.1. Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. HLA Typing/Immune System Monitoring
    • 6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6. Metagenomics, Epidemiology & Drug Development
    • 6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7. Agrigenomics & Forensics
    • 6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.8. Consumer Genomics
    • 6.8.1. Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7. Japan Next Generation Sequencing Market: Workflow Business Analysis

  • 7.1. Next Generation Sequencing Market: Workflow Movement Analysis
  • 7.2. Presequencing
    • 7.2.1. Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1. NGS library preparation kits
      • 7.2.1.1.1. NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2. Semiautomated library preparation
      • 7.2.1.2.1. Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3. Automated library preparation
      • 7.2.1.3.1. Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3. Sequencing
    • 7.3.1. Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Data Analysis
    • 7.4.1. Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2. Primary Data Ngs Analysis
      • 7.4.2.1. Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Secondary Data Analysis
      • 7.4.3.1. Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. Tertiary Data Analysis
      • 7.4.4.1. Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Japan Next Generation Sequencing Market: End-use Business Analysis

  • 8.1. Next Generation Sequencing Market: End-use Movement Analysis
  • 8.2. Academic Research
    • 8.2.1. Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3. Clinical Research
    • 8.3.1. Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotech Entities
    • 8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6. Other Users
    • 8.6.1. Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share analysis, 2023
  • 9.4. Participants Overview
    • 9.4.1. Illumina, Inc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. QIAGEN
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific, Inc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. BGI
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Pacific Biosciences
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Bio Rad Laboratories
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Oxford Nanopore Technologies, Inc
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Myriad Genetics. Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Agilent Technologies, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Eurofins Scientific
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Japan next generation sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 Japan next generation sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Japan next generation sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Japan next generation sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Japan next generation sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Japan next generation sequencing market: market outlook
  • Fig. 7 Japan next generation sequencing competitive insights.
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook.
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 Industry value chain analysis
  • Fig. 12 Japan next generation sequencing market driver impact
  • Fig. 13 Japan next generation sequencing market restraint impact
  • Fig. 14 Japan next generation sequencing market strategic initiatives analysis
  • Fig. 15 Japan next generation sequencing market: Technology movement analysis
  • Fig. 16 Japan next generation sequencing market: Technology outlook and key takeaways
  • Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Whole genome sequencing market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 21 Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Japan Next-generation sequencing market: Product outlook key takeaways
  • Fig. 23 Japan Next-generation sequencing market: Product movement analysis
  • Fig. 24 Platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Japan next generation sequencing Market: Application Movement Analysis
  • Fig. 32 Japan next generation sequencing market: Application outlook and key takeaways
  • Fig. 33 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 PGT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Japan next generation sequencing market: workflow movement analysis
  • Fig. 58 Japan next generation sequencing market: workflow outlook and key takeaways
  • Fig. 59 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan Next generation sequencing market End-use outlook key takeaways
  • Fig. 69 Japan Next-generation sequencing market: End-use movement analysis
  • Fig. 70 Academic research market estimates and forecast, 2018 - 2030 (USD Million))
  • Fig. 71 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Other users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Market share of key market players- Japan next generation sequencing market